Search

Gimv NV

Fechado

SetorFinanças

46.35 3.23

Visão Geral

Variação de preço das ações

24h

Atual

Mín

44.5

Máximo

46.35

Indicadores-chave

By Trading Economics

Rendimento

127M

Vendas

-49M

65M

P/E

Médio do Setor

7.821

28.186

EPS

3.4

Rendimento de Dividendos

5.68

Margem de lucro

195.239

Funcionários

94

EBITDA

52M

128M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.68%

4.24%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

77M

1.7B

Abertura anterior

43.12

Fecho anterior

46.35

Sentimento de Notícias

By Acuity

50%

50%

180 / 493 Ranking em Finance

Gimv NV Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de jan. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 de jan. de 2026, 00:00 UTC

Ganhos

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 de jan. de 2026, 23:47 UTC

Conversa de Mercado

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 de jan. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 de jan. de 2026, 23:39 UTC

Conversa de Mercado

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 de jan. de 2026, 23:32 UTC

Conversa de Mercado

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 de jan. de 2026, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 de jan. de 2026, 22:53 UTC

Aquisições, Fusões, Aquisições de Empresas

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 de jan. de 2026, 22:17 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

14 de jan. de 2026, 22:17 UTC

Conversa de Mercado

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 de jan. de 2026, 22:09 UTC

Ganhos

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 de jan. de 2026, 22:08 UTC

Ganhos

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 de jan. de 2026, 22:08 UTC

Ganhos

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 de jan. de 2026, 21:53 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 de jan. de 2026, 21:53 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 de jan. de 2026, 21:52 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Announces Positive Profit Alert for 2025

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Citigroup Acting as Financial Advisor to WuXi XDC

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

14 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

14 de jan. de 2026, 21:49 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 de jan. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 de jan. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Makes Cash Offer for BioDlink International

14 de jan. de 2026, 21:13 UTC

Conversa de Mercado

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 de jan. de 2026, 20:30 UTC

Conversa de Mercado
Ganhos

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 de jan. de 2026, 20:13 UTC

Conversa de Mercado

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 de jan. de 2026, 20:08 UTC

Conversa de Mercado

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 de jan. de 2026, 19:33 UTC

Conversa de Mercado

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 de jan. de 2026, 19:06 UTC

Conversa de Mercado
Ganhos

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Gimv NV Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Sentimento

By Acuity

180 / 493 Ranking em Finanças

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat